With a strong background in building animal models and extensive knowledge of genetic T cell engineering, Creative Biolabs is now able to offer specialized animal testing services for assessing the safety and in vivo functionality of T-cell receptor (TCR) gene transfer therapy. Our skilled scientists can design and carry out a number of in vivo assays to assess the initial efficacy and toxicity of the engineered T cells equipped with a TCR of defined virus- or tumor-antigen specificity within a competitive timeline, based on the needs of the clients and the characteristics of a particular TCR.
Learn more: TCR-T animal experiment
